packageAlirocumab

alirocumab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Alirocumab is a monoclonal antibody used to treat dyslipidemias, including conditions such as hyperlipoproteinemia type V and arteriosclerosis. It is authorised in the European Union and is used as a lipid-modifying agent.

Summary written by glm-5.3-flash from Wikidata Q4726914 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:alirocumab
ATC codes:C10AX14
DrugBank:DB09302
Wikidata:Q4726914
molar mass:146000 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown